BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Two Patents Granted To GroPep Limited (GRO.AX)


10/19/2005 5:10:35 PM

Listed Adelaide biopharmaceutical company GroPep Limited (ASX:GRO) has been notified by the European Patent Office that its patent for improved products and manufacturing processes for Whey Growth Factor Extract technology will be granted in major European countries.

Now granted in the USA, Europe, Australia and New Zealand, the patent is one of three patent families protecting the oral mucositis product (PV701) for which GroPep has previously announced positive clinical trial results.

GroPep's Vice President of Commercial Operations, Mr Gregory Moss-Smith, said "The fact that the patent both attracted and survived intense opposition proceedings is an indication of the strength of the patent and its commercial merit."

The Canadian Patent Office has also just granted GroPep a related patent on the Whey Growth Factor technology.

GroPep has licensed these patents to Dutch multi-national DMV Campina and Adelaide-based TGR Biosciences Pty Ltd, to exploit areas outside GroPep's pharmaceutical interests.

GroPep, based at Thebarton, South Australia, listed on the Australian Stock Exchange in August 2000. It specialises in the development, manufacture and commercialisation of biopharmaceuticals and also biologically active proteins for cell culture and biomedical research.

Further Information:

Mr Tony Mitchell
Chief Financial Officer/Investor Relations
Ph: (08) 8354 7700
investorrelations@gropep.com.au



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES